Frontlight ResearchEarly access
Not yet taking people in NetherlandsPhase 1
Oxytocin study in healthy adults to explore migraine-related nerve pathways
Tests oxytocin in healthy adults to study nerve pathways involved in migraine.
Key facts
- Who runs it
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
- Where
- Rotterdam, NetherlandsSee the site
- Trial code
- Registry title
- Oxytocine and migraine
- Status
- Not yet recruiting
- Phase
- Phase 1
- People taking part
- 30 people, planned
- Started
- 1 May 2025
- Planned end
- 31 Dec 2025
- Type of study
- Interventional
- Record updated
- 22 October 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy women to study the trigeminovascular system, which plays a role in migraine.
- Age
- 18 to 64 years
- Sex
- Women only
This trial only enrols healthy participants. The registry sentence this rests on: This is a study in healthy volunteers.
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Netherlands
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Rotterdam, NetherlandsNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Oxytocin study in healthy adults to explore migraine-related nerve pathwaysGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Fit questions
- Built from 2023-504690-21-00, who can take part
- Record updated
- 22 October 2025